Innate Pharma (NASDAQ:IPHA) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reiterated their buy rating on shares of Innate Pharma (NASDAQ:IPHA – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. HC Wainwright currently has a $11.50 target price on the stock. Innate Pharma Stock Down 0.9 % Shares of Innate Pharma stock opened at $2.35 on Wednesday. Innate […]
More Stories
Vanguard Capital Wealth Advisors Decreases Holdings in Adams Natural Resources Fund, Inc. (NYSE:PEO)
Vanguard Capital Wealth Advisors reduced its stake in Adams Natural Resources Fund, Inc. (NYSE:PEO – Free Report) by 15.4% during...
Vanguard Capital Wealth Advisors Sells 3,066 Shares of Blackrock Resources & Commodities Strategy Trust (NYSE:BCX)
Vanguard Capital Wealth Advisors reduced its position in shares of Blackrock Resources & Commodities Strategy Trust (NYSE:BCX – Free Report)...
Vanguard Capital Wealth Advisors Sells 5,000 Shares of Pacific Premier Bancorp, Inc. (NASDAQ:PPBI)
Vanguard Capital Wealth Advisors lessened its stake in Pacific Premier Bancorp, Inc. (NASDAQ:PPBI – Free Report) by 25.0% in the...
Vanguard Capital Wealth Advisors Sells 341 Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD)
Vanguard Capital Wealth Advisors trimmed its holdings in Advanced Micro Devices, Inc. (NASDAQ:AMD – Free Report) by 10.6% in the...
Kinky Friedman, American Singer and Politician, Dies At 79
An American singer, songwriter, humorist, and politician, Kinky Friedman, died on Thursday, June 27 at his Ranch in Austin, Texas,...
OKB Trading Up 2.6% Over Last Week (OKB)
OKB (OKB) traded up 0.2% against the dollar during the twenty-four hour period ending at 10:00 AM E.T. on June...